{"bill": {"#text": " \n", "form": {"current-chamber": {"#tail": " \n", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": " \n", "congress": {"#tail": "\n", "#text": "113th CONGRESS"}, "#tail": " \n", "legis-num": {"#tail": " \n", "#text": "H. R. 660"}, "official-title": {"#tail": " \n", "#text": "To amend the Public Health Service Act to create a National Neuromyelitis Optica Consortium to provide grants and coordinate research with respect to the causes of, and risk factors associated with, neuromyelitis optica, and for other purposes."}, "session": {"#tail": "\n", "#text": "1st Session"}, "distribution-code": {"#tail": " \n", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": " \n", "@date": "20130213", "#text": "February 13, 2013"}, "#tail": " \n", "action-desc": {"#tail": "\n", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was referred to the ", "#text": "Ms. Lee of California", "@name-id": "L000551"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}}, "#text": " \n"}, "legis-type": {"#tail": " \n", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H3E55F8D860E54D9AB32E030C980734F7", "@public-private": "public", "legis-body": {"#tail": " \n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": " \n", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Neuromyelitis Optica Consortium Act"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HCA12324854C940B59EF63405D0D4B5A9"}, {"#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds the following:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n      ", "#text": "Neuromyelitis optica (NMO) is a devastating neurologic disease leading to blindness and paralysis."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H1B3C6813FA214B5ABDC5189CE063E8D7", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "There are an estimated 11,000 patients with NMO in the United States."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H3B8E10379D814358BF51E720441C8D42", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "Women are affected 7 to 9 times more than men, and a large proportion of NMO patients are African-American."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HD546492C5FCF40EFB729D080D92E8D4B", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "The average age at diagnosis is 41 years, but the range is broad and includes children as young as 2 years of age and adults as old as 89 years of age."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H2183B89298104EB19522901FB0D2ADC8", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "NMO incurs substantial costs for affected patients and their families."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "H32BA04D0B32040D2A9BD1A7A2771D6D5", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "The cause of NMO is unknown, but it is hypothesized to be autoimmune in nature."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "H6DF70B985EC6417BA581214B847EBBF5", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "More than 90 percent of NMO patients will suffer recurrent disease and accumulate neurologic disability."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H9D44AD8D800D479AAAAF98C03036D07C", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "Because of their relatively low overall incidence, orphan diseases like NMO frequently do not receive sufficient attention and research funding."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "HB123F6A89097452D9A83BAAB994F245E", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "No single institution has a sufficient number of patients to independently conduct research that will adequately address the cause of NMO."}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "H7935682066B34202A6A59B1E102CD50C", "#text": "\n        "}, {"#tail": " \n", "text": {"#tail": "\n      ", "#text": "There has been no comprehensive study analyzing all relevant clinical, biological, and epidemiological aspects of NMO to identify potential risk factors and biomarkers for NMO."}, "enum": {"#tail": "\n        ", "#text": "(10)"}, "@id": "H2542EFB3F73B4B89B435C7C417EDFB2C", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "We can apply our understanding of NMO to the study of other autoimmune diseases, including multiple sclerosis and systemic lupus erythematosus."}, "enum": {"#tail": "\n        ", "#text": "(11)"}, "@id": "H7D2B8A6AE6FD4CA98965F717AA72BAEE", "#text": "\n        "}], "#text": "\n      ", "@id": "HA8B7AB5D7C164F50958A3976CBA37C67"}, {"#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that there is a need\u2014", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "It is the sense of ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Sense of congress"}, "paragraph": [{"#tail": " \n", "text": {"#tail": " \n", "#text": "to establish and coordinate a multicenter research effort based on collaboration between regional consortia and governmental and nongovernmental entities in order to\u2014"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "H6674888DA6FD421582E1CCCE46D5532A", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n        ", "#text": "comprehensively study the causes of NMO; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HDC03928503F14DF9AB047A9A18542676", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "identify potential biomarkers of disease activity; and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H3B9DA9B00F544BF399E007313D576C1F", "#text": "\n          "}]}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "to encourage a collaborative effort among academic medical centers with epidemiological study groups to gather comprehensive and detailed information for each patient enrolled in those groups, in order to investigate environmental, nutritional, and genetic factors with respect to, and the pathological and epidemiological characteristics of, NMO."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H4CCA2EBD82F5436F83EBE71ABC5E7BCD", "#text": "\n        "}], "#text": "\n      ", "@id": "H71020FF278294A5DA0C894954FF5EBCA"}, {"#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following new section:", "@entity-type": "act", "#text": "section 409J", "@value": "Public Health Service Act/s:409J"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding after ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Part B of title IV of the Public Health Service Act", "@value": "Public Health Service Act/t:IV/pt:B"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 284 et seq.", "@value": "usc/42/284/etseq"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Establishment of the national neuromyelitis optica consortium"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "409K."}, "header": {"#tail": " \n", "#text": "National neuromyelitis optica consortium"}, "subsection": [{"#tail": " \n", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": " \n", "#text": "Establishment of the national neuromyelitis optica consortium"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and in coordination with the ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": ", shall establish, administer, and coordinate a ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the National Institute on Minority Health and Health Disparities", "@value": "National Institute on Minority Health and Health Disparities"}, {"@proposed": "true", "#tail": " (in this section referred to as the ", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "National Neuromyelitis Optica Consortium"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Public Health Service Act/s:409K/ss:a/p:2", "@proposed": "true"}], "#text": "Not later than 1 year after the date of the enactment of this section, the ", "quote": {"#tail": ") for the purposes described in ", "#text": "NNO Consortium"}}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "HA834C06FF7024842817C0C9D2BDABE30"}, {"#tail": " \n", "@id": "H8EF8868E73AE4EFE8EB00C8910D8CCBF", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Purposes"}, "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall be the following:", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, "#text": "The purposes of the "}, "#text": "\n              ", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n              ", "#text": "Providing grants of not fewer than 5 years duration to eligible consortia for the purpose of conducting research with respect to the causes of, and the risk factors and biomarkers associated with, NMO."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H26A61D32A7204F99BAD022BC62DADDD5", "#text": "\n                "}, {"#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ", ongoing guidance and recommendations for the development of the following:", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, "#text": "Assembling a panel of experts to provide, with respect to research funded by the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": " \n", "text": {"#tail": "\n                ", "#text": "A common study design."}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H872B25402DE543BEA66F5C486BC773E2", "#text": "\n                  "}, {"#tail": " \n", "text": {"#tail": " \n", "#text": "Standard protocols, methods, procedures, and assays for collecting from individuals enrolled as study participants a minimum dataset that includes the following:"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": " \n", "text": {"#tail": "\n                  ", "#text": "Complete medical history."}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "HCEDBCE3E28AD49C88F1511E4FF805225", "#text": "\n                    "}, {"#tail": " \n", "text": {"#tail": "\n                  ", "#text": "Neurologic examination."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H245A96F3087B474C98A9EE74880F1BFD", "#text": "\n                    "}, {"#tail": " \n", "text": {"#tail": "\n                  ", "#text": "Biospecimens, including blood, spinal fluid, DNA, and RNA."}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "H853C7D84C2AA473F99260C8439A2F789", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "Radiological data including magnetic resonance imaging (MRI)."}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "HCA18590D0B61406F9173933BF6666651", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H4F0625C9493745D781C22D3BAA70C71D"}, {"#tail": " \n", "text": {"#tail": "\n                ", "#text": "Specific analytical methods for examining data."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HBCE923E76E004E21B5040221DB03EC82", "#text": "\n                  "}, {"#tail": " \n", "text": {"#tail": "\n                ", "#text": "Provisions for consensus review of enrolled cases."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "HDA1BCE28F40849BD94BAE5667B4684B8", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "An integrated data collection network."}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H84C089BE11F843A19FB94B5323A791F3", "#text": "\n                  "}], "#text": "\n                ", "@id": "H6519307AD74C4BBBA3F4981C0E790AFF"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " and to make such data and analysis available to researchers.", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, "#text": "Designating a central laboratory to collect, analyze, and aggregate data with respect to research funded by the "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H4F673B30A8CF4877A4B11E6692D1EE12", "#text": "\n                "}]}, {"#tail": " \n", "@id": "HC11ABE5F3BCC48709F3712F73D8CE4E6", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Eligible consortia"}, "text": {"#tail": " \n", "#text": "To be eligible for a grant under this section, a consortium shall demonstrate the following:"}, "#text": "\n              ", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n              ", "#text": "The consortium has the capability to enroll as research participants a minimum of 25 individuals with a diagnosis of NMO from the consortium\u2019s designated catchment area."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HAC682B89F3D74CCCAAAF8A8427314F6D", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "The designated catchment area of the consortium does not overlap with the designated catchment area of another consortium already receiving a grant under this section."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HD3D925F063FC418198E03F24B25A784E", "#text": "\n                "}]}, {"#tail": " \n", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall submit to ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": " a report with respect to the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"@proposed": "true", "#tail": ", to be made publicly available, including a summary of research funded by the ", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, {"@proposed": "true", "#tail": " and a list of consortia receiving grants through the ", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, {"@proposed": "true", "#tail": ". At the discretion of the ", "@entity-type": "federal-body", "@value": "National Neuromyelitis Optica Consortium", "@entity-parent-id": "7529", "#text": "NNO Consortium"}, {"#tail": ", such report may be combined with other similar or existing reports.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 1 year after the date of the enactment of this section and annually thereafter, the "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Report"}, "#text": "\n              ", "@id": "H6362AF4373DD4F54A07B26BCE77DBC9A"}, {"#tail": "\n          ", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n              ", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "@entity-type": "auth-auth-approp", "#text": "There is authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", to remain available until expended, ", "#text": "$25,000,000 for each of fiscal years 2014 through 2018", "@amount": "25000000", "@year": "2014, 2015, 2016, 2017, 2018"}, "{http://namespaces.cato.org/catoxml}property": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "this section", "@value": "Public Health Service Act/s:409K", "@proposed": "true"}, "#text": "to carry out ", "@name": "purpose"}}}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "#text": "\n                ", "@id": "HDFD82B1761EB499F93D5FF4DF72E71F7"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that funds appropriated to carry out this section should be in addition to funds otherwise available or appropriated to carry out the activities described in this section.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "It is the sense of "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Sense of congress"}, "#text": "\n                ", "@id": "H8FEBA46CBF7647E484F6305D31B89138"}], "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": " \n", "#text": "Authorization of appropriations"}, "#text": "\n              ", "@id": "H38003A39501E46F8889A7D6440F98E44"}], "#text": "\n            ", "@id": "H861C9F7A28904CFDB65F586EC55A06F0"}, {"#tail": "\n        ", "text": {"#tail": " \n", "#text": "For purposes of this section:"}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n            ", "quote": {"#tail": " means a defined area for which population data are available.", "#text": "catchment area"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Catchment area"}, "#text": "\n              ", "@id": "HC59A96B7817B401587CF1245C8AD4DFB"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "quote": {"#tail": " means a partnership of 2 or more universities, health care organizations, or government agencies, or any combination of such entities, serving a designated catchment area.", "#text": "consortium"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Consortium"}, "#text": "\n              ", "@id": "HAF57DC2C3D844681BE7EED68683F5C73"}], "#text": "\n            ", "@id": "H7A4869C483564E6A92866DA724D40354"}], "#text": "\n          ", "@id": "HE2C4836150EC4AD1AFF07D7BCBE5224E"}, "#text": " \n", "@id": "H468E6B6BF85743C8BA74059847552332"}, "#text": "\n      ", "@id": "H6CE16A334FA9400F96C6081D3CA3DF76"}], "#text": " \n", "@id": "H4F3E29F61F5A468BA90059B1C659EF6B"}}}